The decision by Aspen CEO Stephen Saad to defy his bankers 21 years ago and keep, rather than sell, a Port Elizabeth drugs manufacturing facility means the company is ready to play a key global role in the manufacture of a vaccine against Covid-19.

A deal unveiled this week with the $400bn US pharmaceutical giant Johnson & Johnson (J&J) positions Aspen to be at the forefront of the battle against the pandemic, which is forcing a growing number of countries back into debilitating lockdowns...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.